Antitumor Agent or Postoperative Adjuvant Chemotherapeutic Agent for Hepatocellular Carcinoma Treatment

• 1. HDS在预测胃癌患者的预后、指导术后辅助化疗和预测免疫治疗疗效中的应用 [P] . 中国专利： CN114134232A . 2022-03-04
• 2. 一种供患者在肠癌根治术后辅助化疗阶段使用的组合物及应用 [P] . 中国专利： CN113648361A . 2021-11-16
• 3. ANTITUMOR AGENT OR POSTOPERATIVE ADJUVANT CHEMOTHERAPEUTIC AGENT FOR TREATMENT OF HEPATOCELLULAR CARCINOMA [P] . 欧洲知识产权局专利： EP2517707A4 . 2013-06-12

  机译： 抗肝癌或术后辅助化疗药

• 4. ANTITUMOR AGENT OR POSTOPERATIVE ADJUVANT CHEMOTHERAPEUTIC AGENT FOR TREATMENT OF HEPATOCELLULAR CARCINOMA [P] . 韩国专利： KR20130012253A . 2013-02-01

  机译： 抗肝癌或术后辅助化疗药

• 5. ANTITUMOR AGENT OR POSTOPERATIVE ADJUVANT CHEMOTHERAPEUTIC AGENT FOR HEPATOCELLULAR CARCINOMA TREATMENT [P] . 美国专利： US2013116298A1 . 2013-05-09

  机译： 肝细胞癌的抗肿瘤药物或术后辅助化疗药物

• 1. Quantitative examination of the inhibitory activation of molecular targeting agents in hepatocellular carcinoma patient-derived cell invasion via a novel in vivo tumor model [J] . Huiwei Sun, Jun Hou, Fan Feng, 动物模型与实验医学（英文） . 2019,第004期
• 2. Chemotherapeutic agents for the treatment of hepatocellular carcinoma: efficacy and mode of action [J] . Saad Shaaban, Amr Negm, Elsayed E. Ibrahim, Oncology Reviews . 2014,第1期
• 3. Chemotherapeutic agents for the treatment of hepatocellular carcinoma: efficacy and mode of action [J] . Saad Shaaban, Amr Negm, Elsayed E. Ibrahim, Oncology Reviews . 2014,第1期
• 4. Effects of palifermin on antitumor activity of chemotherapeutic and biological agents in human head and neck and colorectal carcinoma xenograft models. [J] . Brake R, Starnes C, Lu J, Molecular cancer research: MCR . 2008,第8期
• 5. Useful Combination Therapy of Anti-angiogenic Agent with Chemotherapeutic Agents or RadionuclideTherapy for Cancer Treatment [C] . Sun-Ju Choi, So-Young Lee, Young-Don Hong Controlled Release Society Annual Meeting and Exposition . 2007
• 6. Therapeutic Effect of Adenovirus- and alpha-fetoprotein Promoter-mediated tBid and Chemotherapeutic Agents in Combination on Orthotopic Hepatocellular Carcinoma in Mice. [D] . Ma, Shihong. 2010
• 7. Chemotherapeutic Agents for the Treatment of Hepatocellular Carcinoma: Efficacy and Mode of Action [O] . Saad Shaaban, Amr Negm, Elsayed E. Ibrahim, 2014
• 8. Chemotherapeutic agents for the treatment of hepatocellular carcinoma: efficacy and mode of action [O] . Saad Shaaban, Amr Negm, Elsayed E. Ibrahim, 2014

• 1. Targeted agents for second-line treatment of advanced hepatocellular carcinoma [J] . Nicola Personeni ,Tiziana Pressiani ,Silvia Bozzarelli . 世界胃肠肿瘤学杂志：英文版（电子版） . 2019,第10期
• 2. Antitumor effect of Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, combined with cytotoxic agent on murine hepatocellular carcinoma [J] . Bu-DongZhu ,Shou-JunYuan ,Qi-ChengZhao . 世界胃肠病学杂志：英文版 . 2005,第9期
• 3. Tamoxifen combined with octreotide or regular chemotherapeutic agents in treatment of primary liver cancer: a randomized controlled trial [J] . . 国际肝胆胰疾病杂志：英文版 . 2003,第2期
• 4. Current status of first-line therapy,anti-angiogenic therapy and its combinations of other agents for unresectable hepatocellular carcinoma [J] . Saleh A Alqahtani ,Massimo G Colombo . 世界胃肠肿瘤学杂志:英文版(电子版) . 2021,第12期
• 5. 奥沙利铂联合替吉奥与索拉非尼单药治疗晚期肝细胞癌的对比分析 [C] . 吕宇锋 ,胡晓桦 . 第八届中国肿瘤学术大会暨第十三届海峡两岸肿瘤学术会议 . 2014
• 6. 非小细胞肺癌术后辅助化疗对比中医药治疗对生存的影响 [A] . 唐振豪 . 2020